Home › Funds › Flat Footed LLC › OBIO

Flat Footed LLC position in OBIO

ORCHESTRA BIOMED HLDGS INC · Health Care

Flat Footed LLC reported holding 251,372 shares of OBIO (ORCHESTRA BIOMED HLDGS INC) in its Q2 2026 13F filing — a position valued at US$1.1M, representing 0.09% of its reported portfolio and ranking #37 among its reported holdings. Flat Footed LLC first reported this position in Q2 2026.

Latest position (Q2 2026)251.37K sh
Reported value held$1.08M
Portfolio Weight0.09%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Flat Footed LLC's OBIO position evolved

Flat Footed LLC first disclosed a stake in OBIO in Q2 2026 at 251,372 shares (US$1.1M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 251.37K $1.08M New

About OBIO and 13F data

OBIO (ORCHESTRA BIOMED HLDGS INC) is a Health Care company. 44 other funds we track also report a position in OBIO — the largest reported positions include RTW INVESTMENTS, LP (US$41.2M), Propel Bio Management, LLC (US$3.9M), Knott David M Jr (US$1.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OBIO

All OBIO fund holders →

FAQ

How long has Flat Footed LLC held OBIO?

Flat Footed LLC has disclosed OBIO holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Flat Footed LLC's current position in OBIO?

As of Q2 2026, Flat Footed LLC holds 251.37K shares of OBIO (ORCHESTRA BIOMED HLDGS INC), valued at $1.08M, representing 0.09% of its reported portfolio and ranking #37.

Has Flat Footed LLC been buying or selling OBIO?

In the latest 13F filing (Q2 2026), Flat Footed LLC newly opened its position in OBIO.

Which other funds hold OBIO?

Other major institutional holders of OBIO include RTW INVESTMENTS, LP, Propel Bio Management, LLC, Knott David M Jr, among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.